Characterization and inhibition of AF10-mediated interaction

Hagen S, Mattay D, Raeuber C, Müller K, Arndt KM (2014)
Journal of Peptide Science 20(6): 385-397.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Abstract
The non-random chromosomal translocations t(10;11)(p13;q23) and t(10;11)(p13;q14-21) result in leukemogenic fusion proteins comprising the coiled coil domain of the transcription factor AF10 and the proteins MLL or CALM, respectively, and subsequently cause certain types of acute leukemia. The AF10 coiled-coil domain, which is crucial for the leukemogenic effect, has been shown to interact with GAS41, a protein previously identified as the product of an amplified gene in glioblastoma. Using sequential synthetic peptides, we mapped the potential AF10/GAS41 interaction site, which was subsequently be used as scaffold for a library targeting the AF10 coiled-coil domain. Using phage display, we selected a peptide that binds the AF10 coiled-coil domain with higher affinity than the respective coiled-coil region of wild-type GAS41, as demonstrated by phage ELISA, CD, and PCAs. Furthermore, we were able to successfully deploy the inhibitory peptide in a mammalian cell line to lower the expression of Hoxa genes that have been described to be overexpressed in these leukemias. This work dissects molecular determinants mediating AF10-directed interactions in leukemic fusions comprising the N-terminal parts of the proteins MLL or CALM and the C-terminal coiled-coil domain of AF10. Furthermore, it outlines the first steps in recognizing and blocking the leukemia-associated AF10 interaction in histiocytic lymphoma cells and therefore, may have significant implications in future diagnostics and therapeutics. Copyright (c) 2014 European Peptide Society and John Wiley & Sons, Ltd.
Publishing Year
ISSN
PUB-ID

Cite this

Hagen S, Mattay D, Raeuber C, Müller K, Arndt KM. Characterization and inhibition of AF10-mediated interaction. Journal of Peptide Science. 2014;20(6):385-397.
Hagen, S., Mattay, D., Raeuber, C., Müller, K., & Arndt, K. M. (2014). Characterization and inhibition of AF10-mediated interaction. Journal of Peptide Science, 20(6), 385-397.
Hagen, S., Mattay, D., Raeuber, C., Müller, K., and Arndt, K. M. (2014). Characterization and inhibition of AF10-mediated interaction. Journal of Peptide Science 20, 385-397.
Hagen, S., et al., 2014. Characterization and inhibition of AF10-mediated interaction. Journal of Peptide Science, 20(6), p 385-397.
S. Hagen, et al., “Characterization and inhibition of AF10-mediated interaction”, Journal of Peptide Science, vol. 20, 2014, pp. 385-397.
Hagen, S., Mattay, D., Raeuber, C., Müller, K., Arndt, K.M.: Characterization and inhibition of AF10-mediated interaction. Journal of Peptide Science. 20, 385-397 (2014).
Hagen, Sven, Mattay, Dinah, Raeuber, Christina, Müller, Kristian, and Arndt, Katja M. “Characterization and inhibition of AF10-mediated interaction”. Journal of Peptide Science 20.6 (2014): 385-397.
This data publication is cited in the following publications:
This publication cites the following data publications:

53 References

Data provided by Europe PubMed Central.

Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C, Chen L, Heinrich M, Baus D, Pfitzner E, Zornig M, Ottmann OG, Grez M., Cancer Res. 67(5), 2007
PMID: 17332359
WebLogo: a sequence logo generator.
Crooks GE, Hon G, Chandonia JM, Brenner SE., Genome Res. 14(6), 2004
PMID: 15173120
Sequence logos: a new way to display consensus sequences.
Schneider TD, Stephens RM., Nucleic Acids Res. 18(20), 1990
PMID: 2172928

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 24692230
PubMed | Europe PMC

Search this title in

Google Scholar